The market valuation has significantly increased, with analysts anticipating further growth in response to rising global obesity rates, leading to expanded treatment options and accessible GLP-1 therapies in various regions, further developing this vital segment of the pharmaceutical industry
The role of transcranial direct current stimulation (tDCS) in memory improvement has also been investigated as a possible intervention strategy that could promote the BDNF signaling pathway [379, 380]
Apart from their insulinotropic effects, their GI effects provide therapeutic possibilities for a wide scale of GI diseases, including functional dyspepsia, dumping syndrome, IBS, IBD, short bowel syndrome, NAFLD/NASH and cholestatic disorders
Research Use Only: Klow peptide is intended exclusively for laboratory research and scientific investigation